Fracture healing in osteoporosis - Cellular defects and alterations of regulation;Zelluläre defekte und regulations - Störungen bei der heilung osteoporotischer frakturen

Osteologie

Volumn 20, Issue 1, 2011, Pages 23-28

  Jakob, Franz ^a   Benisch, P ^a   Ebert, R ^a   Seefried, L ^a   Schieker, M ^b   Ignatius, A ^c  

^a UNIVERSITY OF WÜRZBURG   (Germany)

^b UNIVERSITY OF MUNICH   (Germany)

^c UNIVERSITY OF ULM   (Germany)

Author keywords

"Secreted frizzled related proteins" (SFRP); Aging; Fracture healing; Mechanotransduction; Osteoporosis; Sclerostin; Wnt frz signaling pathway

Indexed keywords

SCLEROSTIN; SECRETED FRIZZLED RELATED PROTEIN 1; SEX HORMONE;

AGE DETERMINATION; BONE REGENERATION; CELL FUNCTION; CELL MIGRATION; COLONY FORMING CELL; CONSENSUS; DISEASE COURSE; EXPERIMENTAL MODEL; FEMUR FRACTURE; FIXATION FAILURE; FRACTURE HEALING; FRACTURE IMMOBILIZATION; FRACTURE NONUNION; FRAGILITY FRACTURE; HEALING IMPAIRMENT; HORMONE DEFICIENCY; HUMAN; HUMERUS FRACTURE; HYPOTHESIS; INTERVENTION STUDY; MECHANOTRANSDUCTION; MEDICAL SOCIETY; MESENCHYMAL STEM CELL; MONOGENIC DISORDER; NONHUMAN; OSTEOPOROSIS; PROTEIN EXPRESSION; RADIUS FRACTURE; REVIEW; RISK FACTOR; SENESCENCE; SPINE FRACTURE; VERTEBRA FRACTURE; WNT SIGNALING PATHWAY;

EID: 79955517396     PISSN: 10191291     EISSN: None     Source Type: Journal    
DOI: 10.1055/s-0037-1619975     Document Type: Review

References (75)

1. Gruber R, Koch H, Doll BA et al. Fracture healing in the elderly patient. Exp Gerontol 2006; 41 (11): 1080-1093. (Pubitemid 44820727)
2. Kloss FR, Gassner R. Bone and aging: effects on the maxillofacial skeleton. Exp Gerontol 2006; 41 (2): 123-129. (Pubitemid 43165685)
3. Stromsoe K. Fracture fixation problems in osteoporosis. Injury 2004; 35 (2): 107-113. (Pubitemid 38088021)
4. Nikolaou VS, Efstathopoulos N, Kontakis G et al. The influence of osteoporosis in femoral fracture healing time. Injury 2009; 40 (6): 663-668.
5. Giannoudis P, Tzioupis C, Almalki T, Buckley R. Fracture healing in osteoporotic fractures: is it really different? A basic science perspective. Injury 2007; 38 (Suppl 1): S90-S99. (Pubitemid 46440934)
6. Seefried L, Ebert R, Müller-Deubert S et al. Mechanotransduktion im Alter und bei Osteoporose. Osteologie 2010; 19 (3): 232-239.
7. Komatsu DE, Warden SJ. The control of fracture healing and its therapeutic targeting: improving upon nature. J Cell Biochem 2010; 109 (2): 302-311.
8. Schiessl H, Frost HM, Jee WS. Estrogen and bone-muscle strength and mass relationships. Bone 1998; 22 (1): 1-6. (Pubitemid 28033646)
9. Jakob F, Benisch P, Klotz B et al. Sexualsteroide in der Homöostase des Knochens (Sex steroids in bone homeostasis). Osteologie 2010; 19 (2): 105-110.
10. Imai Y, Kondoh S, Kouzmenko A, Kato S. Minireview: osteoprotective action of estrogens is mediated by osteoclastic estrogen receptor-alpha. Mol Endocrinol 2010; 24 (5): 877-885.
11. Khosla S. Update on estrogens and the skeleton. J Clin Endocrinol Metab 2010; 95 (8): 3569-3577.
12. Rochira V, Carani C. Aromatase deficiency in men: a clinical perspective. Nat Rev Endocrinol 2009; 5 (10): 559-568.
13. Ralston SH. Genetics of osteoporosis. Ann N Y Acad Sci 2010; 1192: 181-189.
14. Richards JB, Kavvoura FK, Rivadeneira F et al. Collaborative meta-analysis: associations of 150 candidate genes with osteoporosis and osteoporotic fracture. Ann Intern Med 2009; 151 (8): 528-537.
15. Lim SK, Won YJ, Lee HC et al. A PCR analysis of ERalpha and ERbeta mRNA abundance in rats and the effect of ovariectomy. J Bone Miner Res 1999; 14 (7): 1189-1196. (Pubitemid 29314063)
16. Stuermer EK, Sehmisch S, Rack T et al. Estrogen and raloxifene improve metaphyseal fracture healing in the early phase of osteoporosis. A new fracture- healing model at the tibia in rat. Langenbecks Arch Surg 2010; 395 (2): 163-172.
17. Melhus G, Brorson SH, Baekkevold ES et al. Gene expression and distribution of key bone turnover markers in the callus of estrogen-deficient, vitamin D-depleted rats. Calcif Tissue Int 2010; 87 (1): 77-89.
18. Kolios L, Hoerster AK, Sehmisch S et al. Do estrogen and alendronate improve metaphyseal fracture healing when applied as osteoporosis prophylaxis? Calcif Tissue Int 2010; 86 (1): 23-32.
19. Beil FT, Barvencik F, Gebauer M et al. Effects of estrogen on fracture healing in mice. J Trauma 2010; 69 (5): 1259-1265.
20. Hatano H, Siegel HJ, Yamagiwa H et al. Identification of estrogen-regulated genes during fracture healing, using DNA microarray. J Bone Miner Metab 2004; 22 (3): 224-235. (Pubitemid 38660953)
21. Cao Y, Mori S, Mashiba T et al. Raloxifene, estrogen, and alendronate affect the processes of fracture repair differently in ovariectomized rats. J Bone Miner Res 2002; 17 (12): 2237-2246. (Pubitemid 35416758)
22. Namkung-Matthai H, Appleyard R, Jansen J et al. Osteoporosis influences the early period of fracture healing in a rat osteoporotic model. Bone 2001; 28 (1): 80-86. (Pubitemid 32112065)
23. Hao YJ, Zhang G, Wang YS et al. Changes of microstructure and mineralized tissue in the middle and late phase of osteoporotic fracture healing in rats. Bone 2007; 41 (4): 631-638.
24. Huang AJ, Ettinger B, Vittinghoff E et al. Endogenous estrogen levels and the effects of ultra-low-dose transdermal estradiol therapy on bone turnover and BMD in postmenopausal women. J Bone Miner Res 2007; 22 (11): 1791-1797. (Pubitemid 351235146)
25. Prestwood KM, Kenny AM, Kleppinger A, Kulldorff M. Ultralow-dose micronized 17beta-estradiol and bone density and bone metabolism in older women: a randomized controlled trial. JAMA 2003; 290 (8): 1042-1048. (Pubitemid 37430444)
26. Mehta M, Strube P, Peters A et al. Influences of age and mechanical stability on volume, microstructure, and mineralization of the fracture callus during bone healing: is osteoclast activity the key to age-related impaired healing? Bone 2010; 47 (2): 219-228.
27. Xing Z, Lu C, Hu D et al. Rejuvenation of the inflammatory system stimulates fracture repair in aged mice. J Orthop Res 2010; 28 (8): 1000-1006.
28. Egermann M, Heil P, Tami A et al. Influence of defective bone marrow osteogenesis on fracture repair in an experimental model of senile osteoporosis. J Orthop Res 2010; 28(6): 798-804.
29. Wahl EC, Aronson J, Liu L et al. Restoration of regenerative osteoblastogenesis in aged mice: modulation of TNF. J Bone Miner Res 2010; 25 (1): 114-123.
30. Naik AA, Xie C, Zuscik MJ et al. Reduced COX-2 expression in aged mice is associated with impaired fracture healing. J Bone Miner Res 2009; 24 (2): 251-264.
31. Kasper G, Mao L, Geissler S et al. Insights into mesenchymal stem cell aging: involvement of antioxidant defense and actin cytoskeleton. Stem Cells 2009; 27 (6): 1288-1297.
32. Bajada S, Marshall MJ, Wright KT et al. Decreased osteogenesis, increased cell senescence and elevated Dickkopf-1 secretion in human fracture non union stromal cells. Bone 2009; 45 (4): 726-735.
33. Lu C, Miclau T, Hu D et al. Cellular basis for age-related changes in fracture repair. J Orthop Res 2005; 23 (6): 1300-1307. (Pubitemid 41554661)
34. Li M, Healy DR, Li Y et al. Osteopenia and impaired fracture healing in aged EP4 receptor knockout mice. Bone 2005; 37 (1): 46-54. (Pubitemid 40848417)
35. Augat P, Simon U, Liedert A, Claes L. Mechanics and mechano-biology of fracture healing in normal and osteoporotic bone. Osteoporos Int 2005; 16 (Suppl. 2): S36-S43. (Pubitemid 46232119)
36. Lu C, Hansen E, Sapozhnikova A et al. Effect of age on vascularization during fracture repair. J Orthop Res 2008; 26 (10): 1384-1389.
37. Strube P, Sentuerk U, Riha T et al. Influence of age and mechanical stability on bone defect healing: age reverses mechanical effects. Bone 2008; 42 (4): 758-764.
38. Hollinger JO, Onikepe AO, MacKrell J et al. Accelerated fracture healing in the geriatric, osteoporotic rat with recombinant human platelet-derived growth factor-BB and an injectable beta-tricalcium phosphate/collagen matrix. J Orthop Res 2008; 26 (1): 83-90.
39. Prisby RD, Ramsey MW, Behnke BJ et al. Aging reduces skeletal blood flow, endothelium-dependent vasodilation, and NO bioavailability in rats. J Bone Miner Res 2007; 22 (8): 1280-1288. (Pubitemid 351339710)
40. Blumenfeld I, Srouji S, Lanir Y et al. Enhancement of bone defect healing in old rats by TGF-beta and IGF-1. Exp Gerontol 2002; 37 (4): 553-565. (Pubitemid 34119160)
41. Stenderup K, Justesen J, Eriksen EF et al. Number and proliferative capacity of osteogenic stem cells are maintained during aging and in patients with osteoporosis. J Bone Miner Res 2001; 16 (6): 1120-1129. (Pubitemid 32467156)
42. Abdallah BM, Haack-Sorensen M, Fink T, Kassem M. Inhibition of osteoblast differentiation but not adipocyte differentiation of mesenchymal stem cells by sera obtained from aged females. Bone 2006; 39 (1): 181-188. (Pubitemid 43831783)
43. Stolzing A, Scutt A. Age-related impairment of mesenchymal progenitor cell function. Aging Cell 2006; 5 (3): 213-224. (Pubitemid 43809939)
44. Sethe S, Scutt A, Stolzing A. Aging of mesenchymal stem cells. Ageing Res Rev 2006; 5 (1): 91-116. (Pubitemid 43139669)
45. Stenderup K, Justesen J, Clausen C, Kassem M. Aging is associated with decreased maximal life span and accelerated senescence of bone marrow stromal cells. Bone 2003; 33 (6): 919-926. (Pubitemid 37543568)
46. Duncan EL, Brown MA. Clinical review 2: Genetic determinants of bone density and fracture risk - state of the art and future directions. J Clin Endocrinol Metab 2010; 95 (6): 2576-2587.
47. Xu XH, Dong SS, Guo Y et al. Molecular genetic studies of gene identification for osteoporosis: the 2009 update. Endocr Rev 2010; 31 (4): 447-505.
48. Jepsen KJ, Price C, Silkman LJ et al. Genetic variation in the patterns of skeletal progenitor cell differentiation and progression during endochondral bone formation affects the rate of fracture healing. J Bone Miner Res 2008; 23 (8): 1204-1216. (Pubitemid 352040176)
49. Manigrasso MB, O'Connor JP. Comparison of fracture healing among different inbred mouse strains. Calcif Tissue Int 2008; 82 (6): 465-474.
50. Colburn NT, Zaal KJ, Wang F, Tuan RS. A role for gamma/delta T cells in a mouse model of fracture healing. Arthritis Rheum 2009; 60 (6): 1694-1703.
51. Kellum E, Starr H, Arounleut P et al. Myostatin (GDF-8) deficiency increases fracture callus size, Sox-5 expression, and callus bone volume. Bone 2009; 44 (1): 17-23.
52. Ota N, Takaishi H, Kosaki N et al. Accelerated cartilage resorption by chondroclasts during bone fracture healing in osteoprotegerin-deficient mice. Endocrinology 2009; 150 (11): 4823-4834.
53. Yamaguchi T, Takada Y, Maruyama K et al. Fra- 1/AP-1 impairs inflammatory responses and chondrogenesis in fracture healing. J Bone Miner Res 2009; 24 (12): 2056-2065.
54. Yukata K, Matsui Y, Shukunami C et al. Altered fracture callus formation in chondromodulin-I deficient mice. Bone 2008; 43 (6): 1047-1056.
55. Su N, Yang J, Xie Y et al. Gain-of-function mutation of FGFR3 results in impaired fracture healing due to inhibition of chondrocyte differentiation. Biochem Biophys Res Commun 2008; 376 (3): 454-459.
56. Holstein JH, Garcia P, Histing T et al. Advances in the establishment of defined mouse models for the study of fracture healing and bone regeneration. J Orthop Trauma 2009; 23 (Suppl. 5): S31-S38.
57. Gaur T, Wixted JJ, Hussain S et al. Secreted frizzled related protein 1 is a target to improve fracture healing. J Cell Physiol 2009; 220 (1): 174-181.
58. Komatsu DE, Mary MN, Schroeder RJ et al. Modulation of Wnt signaling influences fracture repair. J Orthop Res 2010; 28 (7): 928-936.
59. Albers J, Schulze J, Gebauer M et al. Control of Bone Formation by the Serpentine Receptor Frizzled-9. J Cell Biochem 2011; in press.
60. Bakker AD, Klein-Nulend J, Tanck E et al. Different responsiveness to mechanical stress of bone cells from osteoporotic versus osteoarthritic donors. Osteoporos Int 2006; 17 (6): 827-833. (Pubitemid 43781495)
61. Stolzing A, Sellers D, Llewelyn O, Scutt A. Diabetes induced changes in rat mesenchymal stem cells. Cells Tissues Organs 2010; 191 (6): 453-465.
62. Sambrook PN. Anabolic therapy in glucocorticoidinduced osteoporosis. N Engl J Med 2007; 357 (20): 2084-2086.
63. Canalis E, Giustina A, Bilezikian JP. Mechanisms of anabolic therapies for osteoporosis. N Engl J Med 2007; 357 (9): 905-916.
64. Jakob F, Seefried L, Ebert R. Pathophysiology of bone metabolism. Internist 2008; 49 (10): 1159-1160, 1162, 1164 passim.
65. Fu L, Tang T, Miao Y et al. Effect of 1,25-dihydroxy vitamin D3 on fracture healing and bone remodeling in ovariectomized rat femora. Bone 2009; 44 (5): 893-898.
66. Doetsch AM, Faber J, Lynnerup N et al. The effect of calcium and vitamin D3 supplementation on the healing of the proximal humerus fracture: a randomized placebo-controlled study. Calcif Tissue Int 2004; 75 (3): 183-188. (Pubitemid 39331646)
67. Barnes GL, Kakar S, Vora S et al. Stimulation of fracture- healing with systemic intermittent parathyroid hormone treatment. J Bone Joint Surg Am 2008; 90 (Suppl 1): 120-127. (Pubitemid 351329130)
68. Aspenberg P, Johansson T. Teriparatide improves early callus formation in distal radial fractures. Acta Orthop 2010; 81 (2): 234-236.
69. Aspenberg P, Genant HK, Johansson T et al. Teriparatide for acceleration of fracture repair in humans: a prospective, randomized, double-blind study of 102 postmenopausal women with distal radial fractures. J Bone Miner Res 2010; 25 (2): 404-414.
70. Habermann B, Kafchitsas K, Olender G et al. Strontium ranelate enhances callus strength more than PTH 1-34 in an osteoporotic rat model of fracture healing. Calcif Tissue Int 2010; 86 (1): 82-89.
71. Hao Y, Dai K, Guo L et al. Effects of recombinant human growth hormone (r-hGH) on experimental osteoporotic fracture healing. Chin J Traumatol 2001; 4 (2): 102-105.
72. Wang JW, Xu SW, Yang DS, Lv RK. Locally applied simvastatin promotes fracture healing in ovariectomized rat. Osteoporos Int 2007; 18 (12): 1641-1650. (Pubitemid 47620312)
73. Skoglund B, Forslund C, Aspenberg P. Simvastatin improves fracture healing in mice. J Bone Miner Res 2002; 17 (11): 2004-2008. (Pubitemid 35239202)
74. Ulrich-Vinther M, Schwarz EM, Pedersen FS et al. Gene therapy with human osteoprotegerin decreases callus remodeling with limited effects on biomechanical properties. Bone 2005; 37 (6): 751-758. (Pubitemid 41773484)
75. Goldhahn J, Scheele WH, Mitlak BH et al. Clinical evaluation of medicinal products for acceleration of fracture healing in patients with osteoporosis. Bone 2008; 43 (2): 343-347.